Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Wilkins

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Biochemical Society Transactions|August 1, 1993
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular diseaseM R Wilkins
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2012
Pulmonary hypertension: the science behind the disease spectrumM R Wilkins
Toxicology Letters|June 8, 2002
What do we want from proteomics in the detection and avoidance of adverse drug reactionsM R Wilkins
The American Journal of Physiology|February 1, 1992
Effect of pharmacological manipulation of endogenous atriopeptin activity on renal functionM R Wilkins, P Needleman
Heart (British Cardiac Society)|November 17, 2001
Progress in, and future prospects for, the treatment of primary pulmonary hypertensionM R Wilkins, J Wharton
Heart (British Cardiac Society)|March 22, 2002
Natriuretic peptide receptors and the heartL King, M R Wilkins
Journal of Theoretical Biology|May 7, 1997
Cross-species protein identification using amino acid composition, peptide mass fingerprinting, isoelectric point and molecular mass: a theoretical evaluationM R Wilkins, K L Williams
Experientia|December 18, 1995
The extracellular matrix of the Dictyostelium discoideum slugM R Wilkins, K L Williams
British Journal of Pharmacology|September 1, 1993
Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious ratJ E Kirk, M R Wilkins
Clinical Medicine (London, England)|May 3, 2001
Genetic and molecular mechanisms of pulmonary hypertensionN W Morrell, M R Wilkins
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Biochemical Society Transactions|August 1, 1993
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular diseaseM R Wilkins
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2012
Pulmonary hypertension: the science behind the disease spectrumM R Wilkins
Toxicology Letters|June 8, 2002
What do we want from proteomics in the detection and avoidance of adverse drug reactionsM R Wilkins
The American Journal of Physiology|February 1, 1992
Effect of pharmacological manipulation of endogenous atriopeptin activity on renal functionM R Wilkins, P Needleman
Heart (British Cardiac Society)|November 17, 2001
Progress in, and future prospects for, the treatment of primary pulmonary hypertensionM R Wilkins, J Wharton
Heart (British Cardiac Society)|March 22, 2002
Natriuretic peptide receptors and the heartL King, M R Wilkins
Journal of Theoretical Biology|May 7, 1997
Cross-species protein identification using amino acid composition, peptide mass fingerprinting, isoelectric point and molecular mass: a theoretical evaluationM R Wilkins, K L Williams
Experientia|December 18, 1995
The extracellular matrix of the Dictyostelium discoideum slugM R Wilkins, K L Williams
British Journal of Pharmacology|September 1, 1993
Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious ratJ E Kirk, M R Wilkins
Clinical Medicine (London, England)|May 3, 2001
Genetic and molecular mechanisms of pulmonary hypertensionN W Morrell, M R Wilkins
Pageof 15